About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT04004754

Outcomes of Complicated CL in Ethiopia Treated With Miltefosine

Cutaneous Leishmaniasis in Ethiopia causes severe dermatological mutilations. Forms that require systemic treatment are cLCL, MCL, and DCL. National guidelines recommend equally all drugs that are als...

Lead sponsor: Institute of Tropical Medicine, Belgium•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Institute of Tropical Medicine, Belgium

Collaborators

University of Gondar
Boru Meda Hospital

Age

2 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Parasitologically or clinically confirmed diagnosis of Leishmaniasis
•Clinical routine care decision to initiate miltefosine

Exclusion Criteria

•Medical emergencies, underlying chronic conditions, or other circumstances that make participation in this study medically or otherwise inadvisable

Related studies

Complex Cutaneous Leishmaniasis Healing Study in Algeria

NCT03292835 · Cutaneous Leishmaniases

A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies

NCT04512742 · Leishmaniasis, Cutaneous Leishmaniases, and more

Cutaneous Leishmaniasis Diagnostic Study

NCT03837431 · Cutaneous Leishmaniases

Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in Belgium

NCT04001335 · Cutaneous Leishmaniases

COMPLETEDPhase 2

Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis

NCT02919605 · Cutaneous Leishmaniases

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 25, 2020Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment94

Start dateMay 2019

Last updatedJun 25, 2020

Condition

Cutaneous Leishmaniases

Locations shown

Boru Meda Hospital

Boru

Gondar University Hospital

Gonder

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 25, 2020Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions